SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001399529-21-000104
Filing Date
2021-06-07
Accepted
2021-06-07 21:32:58
Documents
1
Period of Report
2021-06-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_162311596214632.html 4  
1 FORM 4 wf-form4_162311596214632.xml 4 10378
  Complete submission text file 0001399529-21-000104.txt   11695
Mailing Address 75 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE LEXINGTON MA 02421 617 621 8097
Dicerna Pharmaceuticals Inc (Issuer) CIK: 0001399529 (see all company filings)

IRS No.: 205993609 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 129 ELSIE STREET SAN FRANCISCO CA 94110
Business Address
Doberstein Stephen K (Reporting) CIK: 0001480111 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36281 | Film No.: 211001086